These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34697652)

  • 1. Investigation of the Fused Deposition Modeling Additive Manufacturing I: Influence of Process Temperature on the Quality and Crystallinity of the Dosage Forms.
    Zhang J; Thakkar R; Kulkarni VR; Zhang Y; Lu A; Maniruzzaman M
    AAPS PharmSciTech; 2021 Oct; 22(8):258. PubMed ID: 34697652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
    Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
    Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
    Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
    Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function correlation and personalized 3D printed tablets using a quality by design (QbD) approach.
    Zhang J; Thakkar R; Zhang Y; Maniruzzaman M
    Int J Pharm; 2020 Nov; 590():119945. PubMed ID: 33027633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
    Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
    Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of feed forces to improve process understanding of Fused Deposition Modeling 3D printing and to ensure mass conformity of printed solid oral dosage forms.
    Gottschalk N; Quodbach J; Elia AG; Hess F; Bogdahn M
    Int J Pharm; 2022 Feb; 614():121416. PubMed ID: 34958898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process.
    Goyanes A; Allahham N; Trenfield SJ; Stoyanov E; Gaisford S; Basit AW
    Int J Pharm; 2019 Aug; 567():118471. PubMed ID: 31252147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
    Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
    J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Veering to a Continuous Platform of Fused Deposition Modeling Based 3D Printing for Pharmaceutical Dosage Forms: Understanding the Effect of Layer Orientation on Formulation Performance.
    Kulkarni VR; Chakka J; Alkadi F; Maniruzzaman M
    Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets.
    Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T
    Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Drug Load on the Printability and Solid-State Properties of 3D-Printed Naproxen-Based Amorphous Solid Dispersion.
    Kissi EO; Nilsson R; Nogueira LP; Larsson A; Tho I
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roadmap to 3D-Printed Oral Pharmaceutical Dosage Forms: Feedstock Filament Properties and Characterization for Fused Deposition Modeling.
    Aho J; Bøtker JP; Genina N; Edinger M; Arnfast L; Rantanen J
    J Pharm Sci; 2019 Jan; 108(1):26-35. PubMed ID: 30445005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
    Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
    Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment.
    Okwuosa TC; Sadia M; Isreb A; Habashy R; Peak M; Alhnan MA
    Int J Pharm; 2021 May; 600():120442. PubMed ID: 33675925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
    Alhijjaj M; Belton P; Qi S
    Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailoring amlodipine release from 3D printed tablets: Influence of infill patterns and wall thickness.
    Obeid S; Madžarević M; Ibrić S
    Int J Pharm; 2021 Dec; 610():121261. PubMed ID: 34742830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Printfills: 3D printed systems combining fused deposition modeling and injection volume filling. Application to colon-specific drug delivery.
    Linares V; Casas M; Caraballo I
    Eur J Pharm Biopharm; 2019 Jan; 134():138-143. PubMed ID: 30476539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations-printability-process modulation, with consecutive effects on in vitro release, stability and degradation.
    Ilyés K; Kovács NK; Balogh A; Borbás E; Farkas B; Casian T; Marosi G; Tomuță I; Nagy ZK
    Eur J Pharm Sci; 2019 Mar; 129():110-123. PubMed ID: 30610954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.